| Oct 9 |
NUCDF and Zevra Therapeutics Launch Check Ammonia Campaign to Highlight Critical Importance of Prompt, Accurate Blood Ammonia Testing for Diagnosing Urea Cycle Disorders
|
| Oct 4 |
Zevra Stock Surges Close to 70% in 3 Months: Here's Why
|
| Sep 26 |
Biotech Stock Roundup: BHVN, WVE, ZVRA Stocks Up on Updates, BIIB & UCBs Study Data & More
|
| Sep 25 |
Investors in Zevra Therapeutics (NASDAQ:ZVRA) have seen decent returns of 67% over the past year
|
| Sep 25 |
Zevra Therapeutics (ZVRA) Moves 9.1% Higher: Will This Strength Last?
|
| Sep 24 |
Zevra started at market outperform by JMP on Miplyffa approval
|
| Sep 24 |
Zevra Therapeutics to Present Top-Line Data from the Phase 2 Clinical Trial of KP1077 for Idiopathic Hypersomnia at Sleep Europe 2024
|
| Sep 23 |
FDA approves Zevra Therapeutics’ Miplyffa for Niemann-Pick disease
|
| Sep 20 |
Zevra Therapeutics' Drug Becomes First FDA-Approved Treatment For Ultra-Rare Neurodegenerative Disease
|
| Sep 20 |
Zevra Therapeutics’ MIPLYFFA™ (arimoclomol) Receives U.S. FDA Approval as Treatment for Niemann-Pick Disease Type C
|
